Showing results (111-120 of 234) with videos related to

Sort By:
Pageof 24
The Annals of Pharmacotherapy|June 25, 2015
Is Fluconazole or an Echinocandin the Agent of Choice for CandidemiaGregory A Eschenauer, Minh-Hong Nguyen, Cornelius J Clancy
Antimicrobial Agents and Chemotherapy|April 20, 2021
Outpatient Fluoroquinolone Prescription Fills in the United States, 2014 to 2020: Assessing the Impact of Food and Drug Administration Safety WarningsDeanna J Buehrle, Marilyn M Wagener, Cornelius J Clancy
Antimicrobial Agents and Chemotherapy|January 9, 2019
Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant EnterobacteriaceaeWilliam R Wilson, Ellen G Kline, Chelsea E Jones, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2013
Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenemsJae H Hong, Cornelius J Clancy, Shaoji Cheng, et al.
Transplantation|August 2, 2016
Surgical Site Infections After Liver Transplantation: Emergence of Multidrug-Resistant Bacteria and Implications for Prophylaxis and Treatment StrategiesJ Alexander Viehman, Cornelius J Clancy, Lloyd Clarke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2021
Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant RecipientsM Hong Nguyen, Ryan K Shields, Liang Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2016
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae InfectionsRyan K Shields, Brian A Potoski, Ghady Haidar, et al.
Infection and Immunity|October 22, 2005
The role of Candida albicans NOT5 in virulence depends upon diverse host factors in vivoShaoji Cheng, Cornelius J Clancy, Mary Ann Checkley, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremiaRyan K Shields, M Hong Nguyen, Brian A Potoski, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2016
Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa IsolatesDeanna J Buehrle, Ryan K Shields, Liang Chen, et al.
Pageof 24